Chromosomal microarray analysis (CMA) and whole exome sequencing (WES) ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 179 | Williams syndrome | 1 |
179. Williams syndrome
Clinical trials : 5 / Drugs : 14 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 32
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04095585 (ClinicalTrials.gov) | September 2014 | 16/9/2019 | Molecular Characterization of Patients Affected by Williams Syndrome and Autism. | Molecular Investigation, Using Chromosomal Microarray and Whole Exome Sequencing, of Patients Affected by Williams Beuren Syndrome and Autism Spectrum Disorder | Williams Beuren Syndrome;Autism Spectrum Disorder | Genetic: chromosomal microarray analysis (CMA) and whole exome sequencing (WES) | Hospices Civils de Lyon | NULL | Completed | N/A | N/A | All | 6 | NULL |